HK StockDetailed Quotes

Provided by TTMF Limited

DIAGENS-BUnlisted

Volume:- -

Turnover:- -

Market Cap:- -

PE:- -

High:- -

Open:- -

Low:- -

Close:- -

52wk High:- -

52wk Low:- -

Shares:80.88M

HK Float Shares:80.88M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

PS:- -

Offering

Mar 20

Closed

Mar 25 09:30

IPO Result

Mar 26

Grey Mkt.

Mar 27 16:15 - 18:30

Listing

Mar 30

Overview Company News Filings

Company Profile

Company Name:

DIAGENS-B

Exchange:

SEHK

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

- -

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Hangzhou Deshi Biotechnology Co., Ltd. (hereinafter referred to as "Deshi Biotechnology") is a global leader in the fields of medical imaging AI and medical imaging equipment, with operations spanning the worldwide market. Leveraging its independently developed general-purpose medical imaging foundation model, iMedImage, the company has successfully built a diversified portfolio of intelligent imaging devices and supporting solutions, including the AutoVision Chromosome Karyotyping System, the MetaSight Automated Cell Microscopy Image Scanning System, the KayoFlow Automated Cell Harvesting and Slide Preparation–Staining Integrated System, and others—each designed to meet the diverse needs of clinical settings. The company's customer base now encompasses more than 400 healthcare centers and medical institutions across China, earning widespread market recognition. Looking ahead, Deshi Biotechnology will continue to provide global customers with standardized intelligent imaging equipment, a Model-as-a-Service (MaaS) cloud platform, and localized self-training solutions, leveraging technological innovation to enhance the efficiency, accuracy, and accessibility of medical imaging diagnostics and thereby spearheading the global medical imaging industry into the era of intelligence.

Directors

Name

Position

SONG Ning

Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee

WENG Zi Xin

Executive Director

Yang Cha

Independent Director,Chairman of the Remuneration and Assessment Committee

ZHANG Jing

Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Chairman of the Audit Committee

WANG Kai Feng

Independent Director,Member of the Nomination Committee,Member of the Audit Committee

XU Chen

Director,Member of the Audit Committee

WU Ling Qian

Director

YANG Ze Hao

Director

Shareholders

Name

Position

SONG Ning

General Manager

WANG Yang

CFO

WENG Zi Xin

COO

SHI Xin Lin

Corporate Secretary

QU Yong Shi

Corporate Secretary

XU Chen

Other Senior Executives

GOU Zheng Meng

Other Senior Executives